Sandy Algaze
@AlgazeSandy
Followers
38
Following
259
Media
0
Statuses
7
Joined November 2017
RT @DrElkhoueiry: Honored to have served as lead investigator on phase I study of botensilimab with expansion in MSS CRC; activity across c….
nature.com
Nature Medicine - In an ongoing phase 1 trial, the combination of two new immunotherapies targeting CTLA-4 and PD-1 was overall well tolerated and elicited encouraging clinical responses in...
0
11
0
RT @CathyEngMD: 🤩@efratdotan presents @NCICTEP_ClinRes @EAOnc EA2186: Randomized Phase II Gem/Nab-Paclitaxel vs. 5-FU/LV/ Liposomal Irinote….
0
20
0
RT @CentralParkWMD: Early signal 🚦 in #PancreaticCancer 💜from the #ADC 💉for #novel target #TF #MRG004A Oral presentation #ASCO24 Manageable….
0
14
0
RT @aakonc: Dr Algaze @AlgazeSandy reports on role of TF in survival of mCRC an analysis of CALGB @SWOG 80405 #ICTHIC24 @ICTHIC
https://t.c….
0
3
0